The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.
about
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening.The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.Publication of interventional phase 3 and 4 clinical trials in radiation oncology: an observational study.
P2860
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.
@en
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.
@nl
type
label
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.
@en
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.
@nl
prefLabel
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.
@en
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.
@nl
P2093
P2860
P1433
P1476
The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.
@en
P2093
Charles D Blanke
Joseph M Unger
Michael LeBlanc
Scott D Ramsey
William E Barlow
P2860
P304
P356
10.1001/JAMAONCOL.2015.6487
P577
2016-03-10T00:00:00Z